Congratulations to Heli Jeskanen, who just won the best poster award related to PMG-AD project in the JPND meeting at Brussels! @UEF_Biomed@UEFNeuroInno@UEFneuroscience
Professori Annakaisa Haapasalo puhuu professuuriesitelmässään aiheesta "Otsalohkodementian translationaalinen tutkimus – molekyylimekanismeista tautibiomarkkereihin ja uusiin hoitoihin".
#professuuriesitelmät#MeOlemmeUEF
Please check our latest findings related to effects of PLCG2 variant on AD pathology @UEFneuroscience@SuomenAkatemia Protective variant in PLCgamma2 mitigates Alzheimer's disease associated pathology via enhancing beneficial microglia functions biorxiv.org/content/10.1101/…
Excellent collaboration with Maria Jose Diogenes group! A small TAT-TrkB peptide prevents BDNF receptor cleavage and restores synaptic physiology in Alzheimer's disease: Molecular Therapy cell.com/molecular-therapy-f…
Pioneering study identifies six genetic regions associated with normal pressure hydrocephalus. Published in Neurology, the study is the first large-scale genome-wide association study related to NPH in the world. @GreenJournal@UEFneuroscience@KuopioNPHuef.fi/en/article/pioneering…
A new preprint from Mikko Hiltunen's group utilises FinnGen to show that the Finnish TYROBP deletion associates with an increased risk and earlier onset of dementia and Alzheimer’s disease in the monoallelic carriers.
Great collaboration with Lambert lab - Neuronal downregulation of PLCG2 impairs synaptic function and elicits Alzheimer disease hallmarks biorxiv.org/content/10.1101/…
"Dementia is not one specific disease, instead it is an overarching term describing a group of diseases characterized by progressive cognitive decline, associated with degeneration of brain matter."
Find out more by reading the post written by our PhD researcher Elena Ppali 🧠